Literature DB >> 17329427

NMDA receptor function and NMDA receptor-dependent phosphorylation of huntingtin is altered by the endocytic protein HIP1.

Martina Metzler1, Lu Gan, Tak Pan Wong, Lidong Liu, Jeffrey Helm, Lili Liu, John Georgiou, Yushan Wang, Nagat Bissada, Kevin Cheng, John C Roder, Yu Tian Wang, Michael R Hayden.   

Abstract

Huntingtin-interacting protein 1 (HIP1) is an endocytic adaptor protein that plays a role in clathrin-mediated endocytosis and the ligand-induced internalization of AMPA receptors (AMPARs) (Metzler et al., 2003). In the present study, we investigated the role of HIP1 in NMDA receptor (NMDAR) function by analyzing NMDA-dependent transport and NMDA-induced excitotoxicity in neurons from HIP1-/- mice. HIP1 colocalizes with NMDARs in hippocampal and cortical neurons and affinity purifies with NMDARs by GST (glutathione S-transferase) pull down and coimmunoprecipitation. A profound decrease in NMDA-induced AMPAR internalization of 75% occurs in neurons from HIP1-/- mice compared with wild type, using a quantitative single-cell-based internalization assay. This defect in NMDA-dependent removal of surface AMPARs is in agreement with the observed defect in long-term depression induction in hippocampal brain slices of HIP1-/- mice and supports a role of HIP1 in AMPAR internalization in vivo. HIP1-/- neurons are partially protected from NMDA-induced excitotoxicity as assessed by LDH (lactate dehydrogenase) release, TUNEL (terminal deoxynucleotidyl transferase-mediated biotinylated dUTP nick end labeling) and caspase-3 activation assays, which points to a role of HIP1 in NMDA-induced cell death. Interestingly, phosphorylation of Akt and its substrate huntingtin (htt) decreases during NMDA-induced excitotoxicity by 48 and 31%, respectively. This decrease is significantly modulated by HIP1, resulting in 94 and 48% changes in P-Akt and P-htt levels in HIP1-/- neurons, respectively. In summary, we have shown that HIP1 influences important NMDAR functions and that both HIP1 and htt participate in NMDA-induced cell death. These findings may provide novel insights into the cellular mechanisms underlying enhanced NMDA-induced excitotoxicity in Huntington's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17329427      PMCID: PMC6673493          DOI: 10.1523/JNEUROSCI.5175-06.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  15 in total

1.  Studies of learning and memory processes in adult rats in conditions of intracerebral administration of caspase inhibitors.

Authors:  E V Markina; Z I Storozheva; V V Sherstnev
Journal:  Neurosci Behav Physiol       Date:  2009-04-02

Review 2.  Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease.

Authors:  Dagmar E Ehrnhoefer; Liza Sutton; Michael R Hayden
Journal:  Neuroscientist       Date:  2011-02-10       Impact factor: 7.519

3.  Recurrent distal 7q11.23 deletion including HIP1 and YWHAG identified in patients with intellectual disabilities, epilepsy, and neurobehavioral problems.

Authors:  Melissa B Ramocki; Magdalena Bartnik; Przemyslaw Szafranski; Katarzyna E Kołodziejska; Zhilian Xia; Jaclyn Bravo; G Steve Miller; Diana L Rodriguez; Charles A Williams; Patricia I Bader; Elżbieta Szczepanik; Tomasz Mazurczak; Dorota Antczak-Marach; James G Coldwell; Cigdem I Akman; Karen McAlmon; Melinda P Cohen; James McGrath; Elizabeth Roeder; Jennifer Mueller; Sung-Hae L Kang; Carlos A Bacino; Ankita Patel; Ewa Bocian; Chad A Shaw; Sau Wai Cheung; Tadeusz Mazurczak; Paweł Stankiewicz
Journal:  Am J Hum Genet       Date:  2010-11-25       Impact factor: 11.025

4.  Dynamics of huntingtin protein interactions in the striatum identifies candidate modifiers of Huntington disease.

Authors:  Todd M Greco; Christopher Secker; Eduardo Silva Ramos; Joel D Federspiel; Jeh-Ping Liu; Alma M Perez; Ismael Al-Ramahi; Jeffrey P Cantle; Jeffrey B Carroll; Juan Botas; Scott O Zeitlin; Erich E Wanker; Ileana M Cristea
Journal:  Cell Syst       Date:  2022-02-10       Impact factor: 11.091

5.  Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease.

Authors:  Eduardo E Arteaga-Bracho; Maria Gulinello; Michael L Winchester; Nandini Pichamoorthy; Jenna R Petronglo; Alicia D Zambrano; Julio Inocencio; Chirstopher D De Jesus; Joseph O Louie; Solen Gokhan; Mark F Mehler; Aldrin E Molero
Journal:  Neurobiol Dis       Date:  2016-09-10       Impact factor: 5.996

6.  HIP1 exhibits an early recruitment and a late stage function in the maturation of coated pits.

Authors:  Irit Gottfried; Marcelo Ehrlich; Uri Ashery
Journal:  Cell Mol Life Sci       Date:  2009-07-22       Impact factor: 9.261

Review 7.  Therapeutic approaches to preventing cell death in Huntington disease.

Authors:  Anna Kaplan; Brent R Stockwell
Journal:  Prog Neurobiol       Date:  2012-08-28       Impact factor: 11.685

8.  Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease.

Authors:  Rona K Graham; Mahmoud A Pouladi; Prasad Joshi; Ge Lu; Yu Deng; Nan-Ping Wu; Bryan E Figueroa; Martina Metzler; Véronique M André; Elizabeth J Slow; Lynn Raymond; Robert Friedlander; Michael S Levine; Blair R Leavitt; Michael R Hayden
Journal:  J Neurosci       Date:  2009-02-18       Impact factor: 6.167

9.  Smaller and larger deletions of the Williams Beuren syndrome region implicate genes involved in mild facial phenotype, epilepsy and autistic traits.

Authors:  Carmela Fusco; Lucia Micale; Bartolomeo Augello; Maria Teresa Pellico; Deny Menghini; Paolo Alfieri; Maria Cristina Digilio; Barbara Mandriani; Massimo Carella; Orazio Palumbo; Stefano Vicari; Giuseppe Merla
Journal:  Eur J Hum Genet       Date:  2013-06-12       Impact factor: 4.246

10.  Huntington's Disease and Striatal Signaling.

Authors:  Emmanuel Roze; Emma Cahill; Elodie Martin; Cecilia Bonnet; Peter Vanhoutte; Sandrine Betuing; Jocelyne Caboche
Journal:  Front Neuroanat       Date:  2011-08-23       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.